C-reactive protein mediates CD11b expression in monocytes through the non-receptor tyrosine kinase, Syk, and calcium mobilization but not through cytosolic peroxides

Inflamm Res. 2005 Dec;54(12):485-92. doi: 10.1007/s00011-005-1382-5.

Abstract

Objective: C-Reactive protein (CRP) can modulate integrin surface expression on monocytes following Fcgamma receptor engagement. We have investigated the signal transduction events causing this phenotypic alteration.

Methods: CRP-induced signalling events were examined in THP-1 and primary monocytes, measuring Syk phosphorylation by Western blotting, intracellular Ca(2+) ([Ca(2+)](i)) by Indo-1 fluorescence and surface expression of CD11b by flow cytometry. Cytosolic peroxides were determined by DCF fluorescence.

Results: CRP induced phosphorylation of Syk and an increase in [Ca(2+)](i) both of which were inhibitable by the Syk specific antagonist, piceatannol. Piceatannol also inhibited the CRP-induced increase in surface CD11b. In addition, pre-treatment of primary monoytes with the Ca(2+) mobiliser, thapsigargin, increased CD11b expression; this effect was accentuated in the presence of CRP but was abolished in the presence of the [Ca(2+)](i) chelator, BAPTA. CRP also increased cytosolic peroxide levels; this effect was attenuated by antioxidants (ascorbate, alpha-tocopherol), expression of surface CD11b not being inhibited by antioxidants alone.

Conclusion: CRP induces CD11b expression in monocytes through a peroxide independent pathway involving both Syk phosphorylation and [Ca(2+)](i) release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antioxidants / pharmacology
  • Blotting, Western
  • C-Reactive Protein / pharmacology
  • C-Reactive Protein / physiology*
  • CD11b Antigen / biosynthesis*
  • CD11b Antigen / genetics
  • Calcium / metabolism*
  • Calcium Signaling
  • Cell Line, Tumor
  • Chelating Agents / pharmacology
  • Egtazic Acid / analogs & derivatives
  • Egtazic Acid / pharmacology
  • Enzyme Precursors / antagonists & inhibitors
  • Enzyme Precursors / metabolism*
  • Flow Cytometry
  • Gene Expression Regulation / drug effects
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Monocytes / immunology*
  • Monocytes / metabolism
  • Peroxides / metabolism*
  • Phosphorylation
  • Protein-Tyrosine Kinases / antagonists & inhibitors
  • Protein-Tyrosine Kinases / metabolism*
  • Receptors, IgG / physiology
  • Signal Transduction
  • Stilbenes / pharmacology
  • Syk Kinase
  • Thapsigargin / pharmacology

Substances

  • Antioxidants
  • CD11b Antigen
  • Chelating Agents
  • Enzyme Precursors
  • Intracellular Signaling Peptides and Proteins
  • Peroxides
  • Receptors, IgG
  • Stilbenes
  • Egtazic Acid
  • Thapsigargin
  • 3,3',4,5'-tetrahydroxystilbene
  • C-Reactive Protein
  • Protein-Tyrosine Kinases
  • SYK protein, human
  • Syk Kinase
  • 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid
  • Calcium